Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 380, Issue 7-8

Issues

Chimeric Restriction Enzymes: What Is Next?

S. Chandrasegaran / J. Smith
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.1999.103

Abstract

Chimeric restriction enzymes are a novel class of engineered nucleases in which the non-specific DNA cleavage domain of FokI (a type IIS restriction endonuclease) is fused to other DNA-binding motifs. The latter include the three common eukaryotic DNA-binding motifs, namely the helix-turn-helix motif, the zinc finger motif and the basic helix-loop-helix protein containing a leucine zipper motif. Such chimeric nucleases have been shown to make specific cuts in vitro very close to the expected recognition sequences. The most important chimeric nucleases are those based on zinc finger DNA-binding proteins because of their modular structure. Recently, one such chimeric nuclease, Zif-QQR-FN was shown to find and cleave its target in vivo. This was tested by microinjection of DNA substrates and the enzyme into frog oocytes (Carroll et al., 1999). The injected enzyme made site-specific double-strand breaks in the targets even after assembly of the DNA into chromatin. In addition, this cleavage activated the target molecules for efficient homologous recombination. Since the recognition specificity of zinc fingers can be manipulated experimentally, chimeric nucleases could be engineered so as to target a specific site within a genome. The availability of such engineered chimeric restriction enzymes should make it feasible to do genome engineering, also commonly referred to as gene therapy.

About the article

Published Online: 2005-06-01

Published in Print: 1999-07-01


Citation Information: Biological Chemistry, Volume 380, Issue 7-8, Pages 841–848, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.1999.103.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Shivam Bhatt and Ronald Chalmers
Nucleic Acids Research, 2019, Volume 47, Number 15, Page 8126
[2]
Austin Burt
Proceedings of the Royal Society of London. Series B: Biological Sciences, 2003, Volume 270, Number 1518, Page 921
[3]
Andrew C. Jamieson, Jeffrey C. Miller, and Carl O. Pabo
Nature Reviews Drug Discovery, 2003, Volume 2, Number 5, Page 361
[4]
Arun Pandian Chandrasekaran, Minjung Song, and Suresh Ramakrishna
Cellular and Molecular Life Sciences, 2017, Volume 74, Number 18, Page 3335
[5]
Hua Fung, David M. Weinstock, and Martin G. Marinus
PLoS ONE, 2011, Volume 6, Number 5, Page e20514
[6]
Shondra M. Pruett-Miller, David W. Reading, Shaina N. Porter, Matthew H. Porteus, and Gregory S. Barsh
PLoS Genetics, 2009, Volume 5, Number 2, Page e1000376
[7]
Matthew H. Porteus
Molecular Therapy, 2006, Volume 13, Number 2, Page 438
[8]
Srinivasan Chandrasegaran and Dana Carroll
Journal of Molecular Biology, 2016, Volume 428, Number 5, Page 963
[9]
Alfred Pingoud, Geoffrey G. Wilson, and Wolfgang Wende
Nucleic Acids Research, 2014, Volume 42, Number 12, Page 7489
[11]
K. M. Vasquez, K. Marburger, Z. Intody, and J. H. Wilson
Proceedings of the National Academy of Sciences, 2001, Volume 98, Number 15, Page 8403
[12]
Y. Xu, K. D. Lunnen, and H. Kong
Proceedings of the National Academy of Sciences, 2001, Volume 98, Number 23, Page 12990
[13]
M. Moore, A. Klug, and Y. Choo
Proceedings of the National Academy of Sciences, 2001, Volume 98, Number 4, Page 1437
[14]
Philippe Ruminy, Céline Derambure, Srinivasan Chandrasegaran, and Jean-Philippe Salier
Journal of Molecular Biology, 2001, Volume 310, Number 3, Page 523
[15]
Birgit Dreier, David J Segal, and Carlos F Barbas
Journal of Molecular Biology, 2000, Volume 303, Number 4, Page 489
[16]
David A. Sorrell and Andreas F. Kolb
Biotechnology Advances, 2005, Volume 23, Number 7-8, Page 431
[17]
Frank Buchholz
Current Opinion in Biotechnology, 2009, Volume 20, Number 4, Page 383
[18]
Mala Mani, Jeff Smith, Karthikeyan Kandavelou, Jeremy M. Berg, and Srinivasan Chandrasegaran
Biochemical and Biophysical Research Communications, 2005, Volume 334, Number 4, Page 1191
[19]
Mala Mani, Karthikeyan Kandavelou, Fei Jamie Dy, Sundar Durai, and Srinivasan Chandrasegaran
Biochemical and Biophysical Research Communications, 2005, Volume 335, Number 2, Page 447
[20]
Nicoletta Corbi, Valentina Libri, Annalisa Onori, and Claudio Passananti
Biochemistry and Cell Biology, 2004, Volume 82, Number 4, Page 428
[21]
Austin Burt and Vassiliki Koufopanou
Current Opinion in Genetics & Development, 2004, Volume 14, Number 6, Page 609
[22]
Yen Choo and Mark Isalan
Current Opinion in Structural Biology, 2000, Volume 10, Number 4, Page 411
[23]
Frédéric Cedrone, André Ménez, and Eric Quéméneur
Current Opinion in Structural Biology, 2000, Volume 10, Number 4, Page 405
[24]
Arunas Silanskas, Michael Foss, Wolfgang Wende, Claus Urbanke, Arunas Lagunavicius, Alfred Pingoud, and Virginijus Siksnys
Biochemistry, 2011, Volume 50, Number 14, Page 2800
[25]
D Segal
Current Opinion in Chemical Biology, 2000, Volume 4, Number 1, Page 34
[26]
Seokjoong Kim and Jin-Soo Kim
Plant Biotechnology Reports, 2011, Volume 5, Number 1, Page 9
[27]
Götz Laible and Lucía Alonso-González
Biotechnology Journal, 2009, Volume 4, Number 9, Page 1278
[28]
Sarah Radecke, Frank Radecke, Toni Cathomen, and Klaus Schwarz
Molecular Therapy, 2010, Volume 18, Number 4, Page 743
[29]
Pei-Qi Liu, Edmond M. Chan, Gregory J. Cost, Lin Zhang, Jianbin Wang, Jeffrey C. Miller, Dmitry Y. Guschin, Andreas Reik, Michael C. Holmes, John E. Mott, Trevor N. Collingwood, and Philip D. Gregory
Biotechnology and Bioengineering, 2010, Page n/a
[30]
Shondra M Pruett-Miller, Jon P Connelly, Morgan L Maeder, J Keith Joung, and Matthew H Porteus
Molecular Therapy, 2008, Volume 16, Number 4, Page 707
[31]
Matthew H Porteus and Dana Carroll
Nature Biotechnology, 2005, Volume 23, Number 8, Page 967
[32]
Yaakov Benenson, Tamar Paz-Elizur, Rivka Adar, Ehud Keinan, Zvi Livneh, and Ehud Shapiro
Nature, 2001, Volume 414, Number 6862, Page 430

Comments (0)

Please log in or register to comment.
Log in